A study to assess impact of sacubitril/valsartan on quality of life of heart failure patients in Portugal in real-world settings assessed by kansas city cardiomyopathy questionnaire
Latest Information Update: 27 Nov 2020
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 27 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research